News New hope for Niemann-Pick Disease Type C treatment as Bloomsbury Genetic Therapies receives Orphan Drug Designations
Web Business Insider: Bramble named among the 23 startups inventing moonshot technology that are set to take off
Web Bloomsbury GTX presents new Preclinical Data on CNS Programs at the European Society of Gene & Cell Therapy (“ESGCT”) Congress 2022
News Phasecraft raises £13m, led by Playground Global, to become the first to reach practical quantum advantage
News Treatment for infantile neuroaxonal dystrophy a step closer as Bloomsbury Genetic Therapies receives Orphan Drug Designations